Press Release CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates 14 hours ago
Press Release CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference Aug 5
Press Release CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB) Aug 4